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MEDICAL REVIEW
The Specialty of Colon and Rectal Surgery:
Its Impact on Patient Care and Role in Academic
Medicinea
Walter E. Longo
Department ofSurgery, Division ofGastrointestinal Surgery,
Yale University School ofMedicine
The specialty ofcolon and rectal surgery, a specialty ofgeneral surgery, has evolvedfrom thefield
ofproctology. Clinical care has demonstrated decreased number ofpatients requiring intestinal
stomas, improved quality oflife in patients with benign anorectal disorders, and morefavorable
results in patients afflicted with primary and recurrent colorectal cancer. Basic science investiga-
tions have spawnedfrom clinical questions such as the molecular biology ofcolorectal cancer, use
ofcyclooxygenase inhibitors andpolyp regression, and novel cytokine antagonists in inflammatory
bowel disease. Medical students are exposed to surgeons with expertise in anorectal anatomy and
physiology, mechanisms ofcarcinogenesis and the importance ofscreeningfordetection ofcolorec-
tal cancer, andnovel therapiesforinflammatory bowel disease. Surgical residents benefitby having
a colorectal surgeon on thefaculty by repetitive exposure to anorectal surgery, lowpelvic anasto-
moses, stoma creation andclosure, andsurgery involving the small intestine. Seniorcolorectal sur-
geons will develop criticalpathwaysfor the healthcare delivery ofpatients afflicted with colorectal
disease. The specialty ofcolorectal surgery will continue to translate into improvedpatientcare and
positively impact in academicmedicine byproviding expertise into studentandresidenttraining and
generate highly sophisticated clinical and basic science investigations.
INTRODUCTION
The controversy over specialization in
medicine has existed for almost 100 years.
Specialization has evolved to provide care
for specific populations, forexplicit services
and as a result ofnew technology. Clearly,
the healthcare market demands driven by
the consumer have championed demands
to no end. Specialization provides state-of-
the-art knowledge and care of complex
areas, high volumes ofroutine procedures,
educational benefits to students and those in
postgraduate training and intangibly pro-
vides the answers to questions that continue
to appear in the clinical arena that need to
be translated from bench research to evi-
denced based medicine. This is all so true
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forthe specialty ofcolon andrectal surgery.
The surgical anatomy is challenging; phys-
iology is better understood but unknown to
those outside the specialty; pharmacology
is playing a crucial role as in the mediators
oftheanalsphincters; andpathology isnever-
ending. Clinically, the issues arechallenging:
fears of stomas in cancer surgery, young
adults undergoing major intestinal resec-
tions for inflammatory bowel disease, life-
altering bowel dysfunction in patients with
fecal incontinence and constipation, and
anal disease that if mismanaged can be
quite costly to the patient and surgeon. The
opportunities for investigation are numer-
ous and include colorectal cancer genetics,
biological therapies for colorectal cancer,
mediators of inflammation, implantable
devices, tissue engineered intestine and
robotics. This review will discuss the spe-
cialty ofcolon andrectal surgery as itrelates
to its evolution, training and board certifi-
cation, spectrum ofclinical activity, educa-
tional initiatives, and frontiers ofresearch.
EVOLUTION OF THE SPECIALTY
It was Frederick Salmon founder of
St. Mark's Hospital, whose interests in anal
fistulas and other diseases of the rectum
attracted his successors, William and Herbert
Allingham, to create the new specialty of
proctology in the mid-1800s. In 1878, it
was the American Dr. Joseph Matthews
who upon noticing that in his practice in
Kentucky a lack of interest and attention
for patients with rectal problems, went to
study with DrWilliamAllingham. Upon his
return to Kentucky, he announced that he
was going to limit his practice to diseases
of the colon and rectum and became
America's first full-time proctologist. He
later became Professor of Surgery in the
Kentucky School ofMedicine and in 1883,
established the Department of Proctology
in the Medical School [1]. Since the 1880s
there have always been a few surgeons
who devoted special attention to colon and
rectal surgery. Until lately, the vast bulk of
bowel surgery remained in the hands of
general surgeons. In the United Kingdom,
surgeons such as Percy Lockhart-Mummery
and John Golligher, paved the way for spe-
cialization in colon and rectal surgery. In
the United States, recognition ofcolon and
rectal surgery as a distinct field has only
becomeevidentoverthepasttwentyyears [2].
AMERICAN BOARD OF COLON
AND RECTAL SURGERY
Since its inception in 1899, the
American Proctologic Society has been
innovative and, above all, concerned with
patients needs. Always moving forward,
members of this society organized and
incorporated into the American Board of
Proctology in 1935. It was the sixth specialty
board to be organized andtenthboard to be
incorporated. After becoming a subsidiary
of the American Board of Surgery from
1935 to 1949, there were continued efforts
for independence. After continuing efforts
to gain independent status, in February
1949, The American Board of Proctology
wasgrantedindependent status. Overthenext
ten years, the Board became active not
only in examining and certifying physi-
cians but also involved in medical educa-
tion. On April 15, 1961, the Advisory
Board for Medical Specialties grated the
American Board of Proctology to adopt
the name The American Board of Colon
and Rectal Surgery. In 1980, the Board
mandated completion of a general surgery
residency and becoming board certified in
general surgery prior to being able to
acquire board certification in Colon and
Rectal Surgery [3, 4].
FELLOWSHIP TRAINING AND
BOARD CERTIFICATION
During the chief-resident year, a
prospective board eligible general surgery
resident makes application through the
National Residency Matching Program for
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surgery. There are currently 41 training
programs in colon and rectal surgery
throughout the United States and Canada.
The number of fellows in each program
ranges from one to four. The fellowship is
of one-year duration of clinical colon and
rectal surgery withcertain programs having
the option foran additional yearofresearch
or further clinical training as a fellow.
Upon completion oftraining, candidates for
board certification in colon and rectal
surgery must be in good standing, submit a
case log to the board, and demonstrate
board certification in general surgery. To
become boardcertified, awritten examina-
tion including sections in pathology and
radiology must be passed (qualifying
examination) and an oral certifying exam-
ination will certify the applicant as board
certified in colon and rectal surgery.
Physicians with an interest and expertise
are encouraged to become amember ofthe
American Society of Colon and Rectal
Surgeons. Recertification for those certified
after 1990 is every ten years.
IMPACT ON PATIENT CARE
Benign anorectal disease
Hemorrhoids: Hemorrhoids are one of
the most common gastrointestinal disor-
ders affecting nearly 5 percent of the
United States population. It is estimated
that two and ahalfmillion persons peryear
visit physicians for treatment [5]. Therapy
can be broadly categorized into oral therapy
such as fiber, topical treatments, nonsurgical
destructive techniques, and surgical inter-
vention. The decision to treat is based on
the nature, frequency, and severity of
symptoms. It is also based upon patient
preference and operator experience. The
overwhelming majority of patients who
seek treatment will receive conservative
therapy where the goal is to relieve symp-
toms and maintain remission. Fiber sup-
plements and increased water intake are
often first-line therapy, however the results
remain inconsistent. Regardless, fiber sup-
plements given over six weeks are superior
versus placebo for reduction of bleeding
symptoms [6]. Itwillremainfirst-linetherapy
because it is safe and inexpensive. Topical
therapies reduce symptoms by exerting a
local anesthestic effect eliminating the
symptoms of burning and itching. A num-
ber oftopical therapies are available. Only
one randomized trial utilizing 5-ASA sup-
positories demonstratedsignificantreduction
in hemorrhoidal symptoms when compared
to placebo [7]. Bleeding or other symp-
toms thatpersistdespite conservative man-
agement require more aggressive therapy.
This entails either non-surgical options or
surgical hemorrhoidectomy. The goal of
non-surgical therapy is tissue fixation of
the hemorrhoid pedicle. These methods
include rubber band ligation, injection
sclerotherapy, and infrared coagulation.
None ofthese techniques have been inves-
tigated individually against placebo-con-
trolled trials [8]. However, randomized tri-
als comparing these modalities with each
other have been performed. These results
failedto demonstrate aclearadvantage and
appear to be equally effective. Two meta-
analyses [9, 10] comparing all three
modalities have been performed. Both trials
demonstrated IRC and RBL to be more
efficacious than sclerotherapy. IRCrequired
repeat treatment, while RBL was signifi-
cantly more painful. The decision to pro-
ceedto surgical hemorrhoidectomy requires
a mutual decision between the patient and
physician and is reserved for patients who
fail non-operative therapy [9]. It is also
indicated for the rare instances of acutely
thrombosed and gangrenous internal hem-
orrhoids. When contemplating surgery, the
risk of complications, postoperative pain,
and cost must be realized. A number of
excisional techniques have been described
and are performed in the operating room
under local, regional, orgeneral anesthesia.
Despite its effectiveness, few patients
should require excisional hemorrhoidectomy.
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bleeding, increased pain and increased
cost. The most significant change in hem-
orrhoid surgery is the use of the circular
stapler. A randomized controlled trial
examining pain, complications, cost, and
recurrence using this modality is underway.
Analfissure: Fissure-in-ano is a com-
mon condition seen by primary care physi-
cians and surgeons. It presents with pain
after defecation that persists for a variable
period oftime and may be associated with
rectal bleeding. Although the pathogenesis
often remains poorly understood, it is felt
to be related to a combination of spasm of
the internal anal sphincter and relative
ischemia of the posterior midline of the
anal canal. Other etiologies of an anal fis-
sure, especially whenlocated away fromthe
midline, should be soughtout. Manometric
studies have demonstrated high resting
anal canal pressures and ultraslow pressure
wave activity in the internal anal sphincter.
Classic treatment involves stool softeners,
fiber supplements, and warm, tub baths.
This will heal about 30 percent offissures.
Ifthe fissure does notheal, then itbecomes
chronic. This is manifest by anatomic signs
such as exposed anal sphincter fibers, sen-
tinel piles, and hypertrophic anal papilla.
The standard classic treatment following
failure of conservative therapy involves a
surgical anal internal sphincterotomy,
which is effective in the overwhelming
majority of patients. Various refinements
in the procedure, open versus closed, par-
tial versus total have occurred [10, 11].
Currently, full thickness, partial, lateral
sphincterotomy is what is supported.
Regardless, division of the internal anal
sphincter may result in variable degrees of
fecal incontinence especially in women
who have undergone vaginal delivery with
occult sphincterdamage. This rare, butdis-
tressing complication, has resulted in sur-
geons seeking alternatives to conventional
sphincterotomy. The neurotransmitter in
the internal anal sphincter leading to relax-
ation is nitric oxide. Chemical sphinctero-
tomy utilizing nitric oxide donors applied
to the anal margin ofpatients with anal fis-
sure have been utilized with variable suc-
cess [12-14]. Alternative agents have also
been investigated. Botulism toxin injection
prevents the release of acetylcholine by
presynaptic nerve terminals and injection
into the internal anal sphincter lasts clini-
cally for three to four months. The internal
anal sphincter has a calcium dependent
mechanism and an extrinsic cholinergic
innervation which can be exploited to
reduce resting anal pressure. Topical dilti-
azem and bethanechol are currently being
investigated and may be additive [16].
Surgery is referred for medical treatment
failures ortomeetimmediatepatientwishes.
Operative techniques commonly used for
anal fissure include anal stretch, open and
closed lateral sphincterotomy, posterior
midline sphincterotomy, and dermal flap
coverage. Anal stretch has a higher risk of
persistence of fissure symptoms when
compared to sphincterotomy and carries a
higher risk of incontinence. There is little
difference between open and closed lateral
internal sphincterotomy regarding persis-
tence offissure andriskofincontinence. Itis
unclear whether posterior midline sphinc-
terotomy should be primary surgical treat-
ment [11]. The management of anal fis-
sures will continue to evolve similar to that
ofhemorrhoids in thattherewill beless anal
sphincterotomies performed in the future.
Fistula-in-ano and abscess: A fistula
is defined as an abnormal communication
between any two epithelial lined surfaces.
A fistula-in-ano is an abnormal tract or
cavity communication with the rectum or
anal canal by an identifiable internal open-
ing. These result, in the majority of cases,
from a previous anorectal abscess and
become a fistula secondary to chronicity.
The classification by Parks is the most
helpful classification currently. There are
four classifications offistula-in-ano: inter-
sphincteric, transsphincteric, suprasphinc-
teric, and extrasphincteric. These are often
cryptoglandular in nature but may also
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and other infectious etiologies. For chal-
lenging cases, especially in the presence of
recurrence, physical examination should be
supplemented with fistulography, intrarectal
ultrasound or magnetic resonance imaging
(MRI)b [17]. It is extremely rare for a fis-
tula-in-ano to heal by conservative mea-
sures. The principles of fistula surgery are
to eliminate the fistula, prevent recurrence,
and preserve sphincter function. The type
offistula will often dictate which operative
procedure should beperformed. Fistulotomy
using the lay-open technique is used for
the treatment of simple intersphincteric
and low trans-sphincteric fistulas. The
problem ofpreserving anal continence and
treating the fistula is more complicated
when treating high intersphincteric fistu-
las. Insertion of a seton in combination
with a lay open technique may be safer in
this situation [18]. In patients with high
trans-sphincteric fistulas and suprasphinc-
teric fistulas, consideration to a anorectal
advancement flap should be given [19].
Extrasphincteric fistulas, whichareexceed-
ingly rare, depend on the etiology (abscess,
Crohn's disease, or foreign body) and
often require fecal diversion along with
eliminating the fistula. Impaired conti-
nence is greatly feared following fistula
surgery. This, along with varying recur-
rence rates have caused surgeons to seek
sphincter muscle sparing techniques to
treat anal fistulas. The use of tissue adhe-
sives or sealants in surgery has increased
because ofimproved autologous and com-
mercially available products. A number of
studies have now demonstrated fistula clo-
sure rates at approximately 85 percent [20,
21]. Functional results have remained
excellent. Future investigations are neces-




Many of the surgical innovations in
surgery have impacted favorably on the
treatment ofulcerative colitis. This includes
the Brooke ileostomy, the ability to suc-
cessfully and safely complete an ileorectal
anastomosis, the Kock continent ileosto-
my, and finally the ileal pouch anal anasto-
mosis. The etiology of ulcerative colitis
remains obscure, however environmental,
dietary and genetic factors continue to be
implicated [22]. It is a disease with a
bimodal peak in age that affects men and
women equally. Innovative medical thera-
pies such as the development and ability to
deliver adequate amounts of 5-ASA com-
pounds to the colon, development ofnovel
steroid compounds with minimal side
effects and immunosuppressive therapies
have all contributed to the well being of
patients [23]. The primary indication for
surgery remains intractability with acute
surgical emergencies less so and surgery
for invasive cancer exceedingly rare.
Aggressive colonoscopic surveillance has
resulted in detection ofdysplasia and mass
lesions, which has hopefully translated
into fewer operations for cancer. Procto-
colectomy with construction ofan ileoanal
reservoir anastomosis is the procedure of
choice and may be either a staged or single
procedure. There remains complications
related to the procedure such as anasto-
motic dehiscence, which may result in
chronic pelvic sepsis or anal stricture as
well as pouch fistula to either the vagina or
perineum. Remedial operations to correct
pouch derangements such as advancement
flaps or creating a neo-reservoir can be
successfully performed in experienced
hands [24]. In properly selected patients,
the ileoanal pouch anastomosis provides
patient satisfaction at over 90 percent [25].
Patients are plagued withpouchitis resulting
in watery diarrhea that often responds to
metronidazole. Probiotics are currently
underinvestigation tobalancepouchecology.
In patients felt not be candidates for a
restorative operation, proctocolectomy and
Brooke ileostomy improves quality of life
and rids the patient of medication. In
patients who have had a previous procto-
colectomy and sacrifice ofthe anal sphinc-68 Longo: The Specialty ofColon and Rectal Surgery
termechanism, acontinentileostomy maybe
considered. Patients with "indeterminate
colitis" have been shown to be candidates
for a restorative proctocolectomy [26].
Crohn's disease
Crohn's disease is associated with
transmural involvement of any portion of
the gastrointestinal tract and, similar to
ulcerative colitis, no specific etiology has
been identified. Medical therapy has
reduced the number ofreoperations and is
also utilized to prevent recurrence after all
gross disease has been removed at surgery.
Because of the nature of this disease,
patients are plagued with obstructive
symptoms secondary to strictures, sepsis
as a result ofperforations and fistulas, and
the challenges of managing their perianal
disease. Clearly, tremendous advances have
been made regarding the potential etiolo-
gies, pathophysiology, diagnostic imaging,
medical therapies, and role of nutritional
supplementation of this disease since its
initial descriptions in theearly 1900s. Efforts
to elaborate on each of these issues is
beyond the scope ofthisarticle, andreaders
are encouraged to review the myriad of
papers addressing each ofthese issues.
Surgery remains an integral part of
treatment and should not be viewed as
doom and gloom. Clearly the results of
operative therapy have dramatically
improved patients quality of life, even in
the setting oftemporary orpermanentfecal
diversion [27]. Surgery for small and large
intestinal disease has evolved from bypass
procedures and extensive intestinal resec-
tion to a more conservative approach
involving conservative surgical therapies.
This has been facilitated by the use of
interventional radiology involving percu-
taneous drainage of abscesses, total par-
enteral nutrition including its use in the
home setting, and the use of medical ther-
apy in the postoperative setting following
resection ofall macroscopic disease. Wide
intestinal anastomoses using linear sta-
pling techniques, the use of limited (< 2
cm) resection margins, and the technique
of strictureplasty has decreased short and
long term morbidity and improved quality
of life [27, 28]. Similarly, conservative
resectional treatment involving the colon
also continues to evolve [29].
Two areas deserve special interest,
they being acute surgical emergencies and
perianal Crohn's disease. The morbidity
and mortality for acute emergencies such
as toxic colitis, hemorrhage and perfora-
tion has somewhat diminished due to
improvements in surgical technique and
intensive care medicine. It is also my per-
ception that patient compliance to medical
care and specialization in gastroenterology
in the area of inflammatory bowel disease
has potentially reduced the number of sur-
gical emergencies.
Perianal Crohn's disease has continued
to plague surgeons because of the fear of
fecal incontinence, uncontrolled pelvic sep-
sis, and the need for removing the patients
rectum necessitating permanent colostomy.
Currently, conservative approaches involving
drainage of abscesses with mushroom
catheters, use ofnon-cutting setons, antibi-
otics, and anti-TNF therapy has resulted in
controlled sepsis andpreservation offunction.
Colorectal cancerscreening
Current colorectal cancer screening
options include fecal occult blood testing,
flexible sigmoidoscopy, air-contrast barium
enema, fiberoptic colonoscopy, virtual
colonoscopy, and stool DNA tests.
Guidelines for screening revolve around
whether you are a high-risk or average-risk
patient as well as the results of the initial
screening procedure. Fecal occult blood
testing is non-invasive, least expensive,
and most widely available but has subopti-
mal sensitivity and prevents the fewest
cancers. Barium enema is inexpensive and
cost-effective but insensitive when com-
pared tocolonoscopy. Fiberopticcolonoscopy
is very sensitive for colorectal lesions, but
is most invasive and costly. Stool DNA
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nology because colorectal cancers contain
genetic mutations or inactivated genes.
The test hopes to identify genetic abnor-
malities in colonocytes shed in the stool.
Early clinical studies suggest that multi-
target, DNA-based stool tests are capable
of detecting both premalignant adenomas
and cancers with high sensitivity and
specificity. This form of testing is attrac-
tive because it is non-invaive, requires no
bowel preparation or dietary restrictions
and requires a single specimen [30].
Screening colonoscopy is cost-effec-
tive and provides high patient satisfaction
because it provides effective diagnosis and
treatment in a single session. Virtual
colonoscopy (Computed tomography [CT]
and MR) colonography performance relies
on the use of state-of-the-art scanners,
computer workstations and trained radiol-
ogists. Both CT and MR colonography
currently report excellent sensitivity equal
tocolonoscopy and the advantage ofMR is
lack ofionizing radiation [31].
Inherited colon cancer
Approximately 80 percent of patients
with colorectal cancer appear to have spo-
radic disease whereas approximately 20
percent have a potentially definable inher-
itable component. Several hereditary syn-
dromes caused by specific germline muta-
tions have been characterized and account
for 5 to 6 percent of all colorectal cancer
patients [32]. These include familial ade-
nomatous polyposis (FAP), hereditary
non-polyposis colorectal cancer (HNPCC),
Peutz-Jeghers syndrome, and juvenile
polyposis. When used appropriately, genetic
testing is available for diagnosis of the
major inherited syndromes of colon can-
cer. FAPis an autosomal dominantly inher-
ited syndrome that arises from germline
mutations ofthe APC (adenomatous poly-
posis coli) gene. Clinically it is character-
ized by the occurrence ofhundreds to thou-
sands ofcolorectal adenomatous polyps at
an early age and inevitably colon cancer
unless colectomy is performed. In addition
to polyps, patients with FAPcan develop a
variety of extracolonic lesions. These
include both benign and malignant tumors.
The diagnosis is confirmed by the pres-
ence of 100 or more adenomas on colono-
scopic examination. Also the diagnosis of
FAP can be confirmed by genetic testing
for the APC gene mutation. It will be pre-
sent in 80 to 90 percent of affected indi-
viduals. If the mutation is found in pedi-
gree, yearly sigmoidoscopy should begin at
age 12, decreasing in frequency after each
decade up to age 50, at which time screen-
ing should conform to American Cancer
Society guidelines foraverage riskpatients
[33]. Surgery is recommended at the time
ofdiagnosis to minimize the risk ofmalig-
nancy. There are several options including
total abdominal colectomy with ileorectal
anastomosis or total proctocolectomy with
either ileostomy or ileoanal pouch anasto-
mosis. If the rectum can be cleared endo-
scopically, rectal preservation is preferred.
Surveillance of the rectum is performed.
Cyclooxygenase inhibitors have been
shown to be effective in inducing regres-
sion ofpolyps in the retained rectum.
HNPCC is an autosomal dominant
inherited disorder that accounts for 3 to 5
percent of all colorectal cases. It is caused
by a mutation in any one of the five mis-
match repairgenes. Colorectal cancerarises
from a single flat polypoid lesion in the
absence ofpolyposis. It is characterized by
ayoung age for developing colorectal can-
cer, multiple tumors, proximal lesions, and
metachronous tumors within 10 years of
resection. Similar to FAP, other cancers
can occur in HNPCC especially gyneco-
logical. The phenomenon on microsatellite
instability is found in 90 percent of
HNPCC tumors and is the first step in
genetic testing followed by MMR gene
testing to confirm the diagnosis. In a
patient with HNPCC who develops col-
orectal cancer, subtotal colectomy with ile-
orectal anastomosis is recommended.
Postoperative endoscopic surveillance
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[34]. It is uncertain whether prophylactic
hysterectomy and oophorectomy isindicated.
Rectal andanal cancer
The management of rectal cancer has
progressed tremendously over the past 100
years, in part because of an increased
understanding ofthe pathology and natural
history of the disease [35]. Currently,
surgery remains the mainstay of therapy
and includes a spectrum of operative pro-
cedures both radical and local with a trend
towards increased number of sphincter
sparing procedures. Preoperative diagnostic
imaging has provided preoperative assess-
ment of locoregional and distant disease
and aids in decisions ofwhether to employ
preoperative neoadjuvant therapy involving
radiation and chemotherapy [35]. Regard-
less, outcome appears to be related to
tumor biology, stage of the lesion at pre-
sentation, and type of operation per-
formed. Recently, the impact of the sur-
geon performing the operation may also
influence outcome [36]. Preoperative imaging
remains an essential part ofthe assessment
ofthepatient withrectal cancer. CTis useful
in assessing patients thoughttoharborexten-
sive local or metastatic disease. Endorectal
ultrasound is the best method for evaluating
loco-regional disease. It is highly accurate
for detecting depth of invasion and less so
forperirectal lymph nodes. Magnetic reso-
nance imaging (MRI) can also detect local
tumor extension. Nuclear medicine tech-
niques utilizing either flurodeoxyglucose
positron emission tomography (FDG-PET)
and immunoscintigraphy are utilized to
detect occult or recurrent cancer [35].
Radiation therapy is an integral part of
treatment for patients with rectal cancer.
Its role is to decrease local recurrence and
hopefully translate into improved survival
rates. In the preoperative setting, radiation
can increase respectability ofbulky lesions
and increase chance of sphincter preserva-
tion in distal lesions. Intraoperative radiation
therapy is applied to locally advanced pri-
mary and recurrent rectal cancer. Postoper-
ative adjuvant chemotherapy has shown
survival benefit with the optimal regimen
evolving.
Anal cancer is rare and accounts for 1
to 6 percent of all anorectal neoplasms. It
is important to distinguish anal canal from
anal margin neoplasms as the former are
more aggressive. The goals of treatment
are cure, local control, sphincter salvage,
and avoiding permanent colostomy. There
remains various histiotypes, with squa-
mous cell being most common while ade-
nocarcinoma arising from the anal glands
and anal melanoma being uncommon.
Throughout the 1970s, abdominoperineal
resection was the standard treatment
resulting in a permanent colostomy, high
local recurrence rates, and low five-year
survival rates. Nigro initiated the force of
change and began the first successful use
of combined fluorouracil and mitomycin
with external beam radiation as potentially
curable therapy [37]. Today modifications
of Nigro's protocol remain the standard of
care for treatment of squamous cell carci-
noma ofthe anal canal. Abdominoperineal
resection remains salvage therapy for
treatment failures with variable survival
rates. Anal adenocarcinoma is treated sim-
ilarly to that of rectal adenocarcinoma
employing surgery with or without adju-
vantchemoradiation. Anal canal melanoma
has a continued poor prognosis where
surgery is the only meaningful method of
treatment with the goal being local control
[38].
Fecal incontinence
Fecal incontinence remains one of the
most devastating conditions. Its exact inci-
denceremains unknown butvaries between
1 to 3 percentand up to 7 percentin healthy
adults over 65 years ofage [39]. There is a
higherratein women secondary toobstetric-
related structural sphincter damage. The
etiologies are numerous and are often related
to obstetrical trauma, previous anal surgery,
rectal prolapse, pelvic floor denervation,
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operations. Fecal incontinence may be
either passive or urgent in nature. Passive
incontinence relates to losses occurring
without patient awareness usually associ-
ated with internal sphincter dysfunction
andreduced maximumresting anal pressure.
Patients with urgency incontinence are
unable to defer defecation, which usually
reflects either external sphincter dysfunc-
tion or excessively strong bowel contrac-
tion that cannot be opposed by the external
sphincter pressure. A careful history and
physical examination is imperative to dif-
ferentiate isolated sphincter dysfunction
from general metabolic and neurologic
disorders. Special physiologic examina-
tions have allowed the physician to permit
assessment of the anal sphincters, puden-
dal nerves, and pelvic floor. These include
anal manometry, cinedefecography, elec-
tromyography, anal ultrasonography, and
magnetic resonance imaging [40].
Many patients can be managed by
means ofpharmaceutical products such as
antidiarrheals or behavioral modification
such as biofeedback. Daily colonic irriga-
tion remains another alternative but has
potential adverse sequelae. A number of
surgical procedures are available for the
treatment ofanal incontinence. Most oper-
ations attempt to restore the sphincter
mechanism and anorectal angle. These
include either anorectal muscle repairs
such as direct apposition and overlapping
sphincteroplasty or total pelvic floor repair
[41]. Severe multifocal damage to the
sphincter complex may not be suitable for
direct sphincter repair and require either a
static or dynamic neosphincter repair [42].
These include gluteus and gracilis muscle
transpositions or free muscle transposi-
tions involving sartorius muscle. Implanta-
tion of an artificial sphincter was initially
popularized in 1992 and remains under
investigation [43]. Finally, the creation of
an intestinal stoma remains the last option
for treatment of incontinence. This can be
performed laparoscopically. Neurogenic
incontinence remains a difficult condition
and may benefit by biofeedback and other
conservative measures [44].
Functional andpelvic floor disorders
The majority offunctional pelvic floor
disorders are the result of or result in
abnormal defecatory habits. Often these
disorders have constipation as the predom-
inant symptom [45]. Sophisticated physio-
logical testing and diagnostic imaging
techniques have identified the etiology of
many of these defecatory disorders and
resulted in therapies to patients who would
have previously been ignored. Paradoxical
or non-relaxing puborectalis syndrome
(anismus) occurs when the puborectalis
inappropriately contracts or fails to relax
during defecation resulting in pelvic outlet
obstruction. The diagnosis is confirmed
with acombination ofanorectal manometry,
electromyography and cinedefecography.
Biofeedback therapy is the initial treat-
ment of choice [46]. Treatment failures
may respond to Botox injections. Surgery
has no role. The Descending Perineum
Syndrome has a similar presentation as
anismus with obstructed defecation as the
predominant symptom. It is felt to be sec-
ondary to many years of straining to defe-
cate. It is diagnosed by perineometric mea-
surements andcinedefecography. Treatment
is limited to nonoperative methods includ-
ing biofeedback. Arectocele may also pro-
duce obstructed defecation. The diagnosis
is made by a history of straining and the
need for digital rectal or vaginal evacua-
tion. Physical examination provides the
diagnosis in about two-thirds of cases
where the rectum is seen bulging into the
vagina. Defecography will reveal the rec-
tocele and provide useful information
about the anorectal angle. Treatment is ini-
tially conservative. Surgery is recommend-
ed for patients rectocele's greater than 4
cm partial emptying during defecography
and the need to digitally evacuate. A wide
range of transvaginal, transrectal, and
transperineal procedures have been advo-
cated with variable success. Rectalprolapse72 Longo: The Specialty ofColon and Rectal Surgery
is full thickness protrusion of the rectum
through the anal sphincters. Internal or
"hidden" prolapse occurs when the rectum
intusscepts, but does not pass beyond the
anal canal. Symptoms include protrusion,
bleeding, fecal incontinence, and a sense
of incomplete rectal emptying. Full thick-
ness rectal prolapse must be differentiated
from rectal mucosal prolapse seen in asso-
ciation with advanced hemorrhoidal dis-
ease. Management of rectal prolapse is
surgical [47]. Over 100 procedures have
been described. They may either be
abdominal or perineal. Normal anatomy is
restored. A widely variable effect of pro-
lapse surgery on disturbed evacuation
occurs. Continence is often restored.
Intestinal stomas and alternatives to
conventional ileostomy
During the first half of the twentieth
century, an ileostomy was associated with
significant morbidity secondary to serosi-
tis of the exposed bowel wall. This was
rectified by the development of the tech-
nique of an everting ileostomy in 1952 by
Brooke [48]. This dramatically changed
surgical treatmentand life with an ileostomy.
Nevertheless, patient dissatisfaction of a
constantly draining stoma and the require-
ment of a full-time pouch caused physi-
cians to develop alternatives. In 1969, Nils
Kock [49] describedthecreation ofan ileal
reservoir drained by an access segment
through therectus muscle. He modifiedthis
with a nipple valve of intusscepted ileum
creating complete continence. A further
modification was proposed by William
Barnett who developed the Barnett reser-
voirutilizing aliving collarofileum wrapped
around the neck of the pouch to improve
continence [50]. The utility ofthese proce-
dures has diminished as a direct conse-
quence of the creation of the ileoanal
pouch for the treatment ofulcerative colitis
and familial adenomatous polyposis.
Although pouch salvage following anal
and perineal complications of restorative
proctocolectomy continue to improve, there
is aroleforacontinent ileal stomaintheeven
the pouch can not be salvaged [51, 52].
Anorectalphysiological testing
Manometric, electrophysiologic and
radiologic techniques used in combination
provide important basic information nec-
essary to understand anorectal and pelvic
floor disorders. Anorectal physiological
testing evaluates the function of the
anorectum, pelvic floor, and anal sphincters
[53]. Its utility centers mostly on the eval-
uation offecal incontinence [54]. The tests
used most frequently are anorectal manom-
etry, pudendal nerve terminal motor laten-
cy, concentric needle EMG, single fiber
EMG, cine defecography, and colonic
transit studies. Anorectal manometry uti-
lizes various catheters probes and record-
ing devices to determine resting sphincter
pressures, anal sphincter length, maximum
squeeze pressures, rectoanal inhibitory
reflex, and rectal sensory volumes. Indica-
tions for anorectal manometry include
evaluating patients with chronic constipa-
tion determining whether the patient has
Hirschprung's disease as evidenced by
absence of the anorectal inhibitory reflex,
to quantitate a sphincter defect and assess
contribution of the neural and muscular
components necessary for fecal conti-
nence. Electromyography is the recording
of electrical activity generated by muscle
fibers and can be measured either during
voluntary contraction or at rest. It is used
to evaluate muscles whose nerve supply
may have been damaged and thus is valu-
able in patients with pelvic floor disorders
and fecal incontinence. It can be recorded
with surface electrodes, concentric needle
electrodes, and single fiber electrodes.
Pudendal nerve terminal motor latency is
best evaluated for anal sphincter injury
secondary to trauma or vaginal delivery
prior to surgical repair and evaluation of
idiopathic fecal incontinence. Concentric
needle EMG allows for selective recording
ofmuscles ofinterest such as the puborec-
talis in patients with anismus [55].Longo: The Specialty ofColon and Rectal Surgery 73
Imaging of the anal sphincters and
pelvic floor
Recent advances in ultrasonography
have improved significantly the accuracy
and applicability of intrarectal and intra-
anal ultrasonography to the management
of benign and malignant diseases of the
anus and rectum. Intrarectal ultrasonogra-
phy has demonstrated a high degree of
accuracy in the assessment of extent of
local invasion ofrectal carcinomas as well
as the degree ofregional lympadenopathy.
It is also capable of detecting occult
anorectal abscesses. In patients with fecal
incontinence, it allows for the identifica-
tion of sphincter defects. Defecography is
a radiologic study in which thickened bar-
ium is introduced into the rectum and the
patient is seated on aradiolucent commode
and instructed to evacuate contrastmaterial.
A video recording is taken in the lateral
projection. Itis useful in evaluating patients
with obstructed defecation in an effort to
determine if patients have anismus, recto-
cele, internal procidentia, orexcessive per-
ineal descent. Colonic transit studies require
patients to ingestradiopaque markers while
receiving a normal diet, without using lax-
atives. Serial radiographs are taken at
specified intervals to determine the speed
with which the markers traverse the colon.
A normal study should pass 80 percent of
the markers by five days. If not, this is
suggestive ofcolonic inertia. MRdefecog-
raphy with an open configuration magnet
allows accurate assessment of anorectal
morphology and function in relation to sur-
rounding structures without exposing the
patient to harmful ionizing radiation [56].
Minimally invasive techniques
The field of laparoscopic colon and
rectal surgery has evolved slowly over the
past decade as compared to other laparo-
scopic procedures. This is mainly due to the
complexities ofthe procedures. Minimally
invasive techniques can involve either
abdominal procedures utilizing standard
laparoscopic instruments or approaches to
the rectum utilizing transanal endoscopic
microsurgery. It is appealing for those who
have pulmonary disease, those who would
benefit from small incisions, and those
who desire cosmesis. Almost every disease
encountered in colon and rectal surgery is
approachable laparoscopically, however,
colorectal cancer patients at this time are
best entered into aprospective randomized
trial. Nevertheless, there remains a steep
learning curve due to the fact thatcolorectal
surgeons do little laparoscopy. Improve-
ments in technology such as hand-assisted
laparoscopy have gained momentum.
Regardless, it is estimated that the number
of colectomies performed by a totally
laparosopic, laparoscopically assisted, or
hand-assisted laparoscopic technique is
nationally less than 10 percent. There is
currently some evidence that a minimally
invasive approach may decrease postoper-
ative ileus, requirements for postoperative
analgesia, length ofhospital stay, and cost.
This is highly institutional dependent.
Regardless minimally invasive approaches
are attractive to patients with polypoid
lesions ofthe colon not amenable to endo-
scopic removal, functional disorders such
as rectal prolapse surgery, and select
patients with inflammatory bowel disease,
It would be premature to define its onco-
logic benefit or risk in colorectal cancer
prior to the maturity ofcurrently undertak-
en prospective randomized trials [57, 58].
For any colorectal surgeon, its utility will
depend upon referral patterns and acuity
and complexity of patients sees in their
daily practice. It is doubtful that colorectal
surgery will be dominated by laparoscopy,
but itwill continue to have aroleinproperly
selected patients.
ROLE IN ACADEMIC MEDICINE
Residentandmedicalstudenteducation
Expertise by the educator often brings
tremendous credibility to the learning
environment. Currently, department chair-74 Longo: The Specialty ofColon and Rectal Surgery
men are recruiting faculty with specializa-
tion within general surgery in an effort to
strengthen not only surgical education but
to grow practices and increase clinical rev-
enues. Popular areas of specialization
include minimally invasive surgery, surgi-
cal oncology, endocrine surgery, and colon
and rectal surgery. Within each of these
disciplines "super specialization" with
exposure, training, and experience in areas
such aslaparoscopic morbidobesity surgery,
inflammatory bowel disease, minimally
invasive parathyroidectomy, soft tissue
sarcomas, and pancreatic neuroendocrine
tumors also lends further credibility. Few
papers have been written regarding the
benefits ofcolon and rectal surgery to sur-
gical education, but the advantages are
obvious [59, 60]. Increased exposure of
uncommon and poorly understood proce-
dures involving the anus, the small intes-
tine as well as creation oflow pelvic anas-
tomoses with or without an intestinal
reservoir has been elegantly reported [61,
62]. Medical studentexposure to surgery is
a limited experience often involving three
to four months of a 48-month curriculum.
When rotating on surgery, there is often
heightened enthusiasm for "knife and gun
club surgery," the cerebral aspects of sur-
gical critical care, and the removal oflarge
tumorsen-blocwithothercontiguousorgans.
However, a medical student may be uncer-
tain about the indications for surgical hem-
orrhoidectomy, believe that all patients
withrectal cancerrequire an abdominoper-
ineal resection, or perceive that women
with fecal incontinence have nothing to be
offered other than acolostomy. As the spe-
cialty of colon and rectal surgery truly
offers the benefits of a complete specialty:
a challenging office practice, sophisticated
diagnostic skills such as ultrasound and
endoscopy, and a plethora of surgical pos-
sibilities involving the abdomen, pelvis,
and perineum, it serves as a good role
model of what a physician is all about.
Furthermore one learns communication
skills, develops personality traits, and prac-
tices ethical behavior when confronted
with the anxiety and attimes the tragedy of
colorectal cancer, the functional limita-
tions offecal incontinence or living with a
stoma, how disease can affect intimacy
and personal relationships, and finally the
effect of disease as it occurs in the late
stages of one's adult life.
Frontiers ofresearch
Three principal areas that will continue
toreceive attention andfunding incolorectal
disease include mechanisms of carcino-
genesis and therapy, suppressing inflamma-
tion and modulating inflammatory media-
tors seen in intestinal inflammatory states
such as Crohn's disease and ulcerative colitis
and finally exploring mechanisms ofintesti-
nal motility and dysmotility as seen in irri-
table bowel syndrome and poor functional
results following operations restoring
intestinal continuity. It is likely that the
majority of the research efforts in colon
and rectal disease will involve cancer. The
continuing advances being made in molec-
ular biology will involve genetic profiling
[63] resulting in identification ofhigh-risk
groups (inherited colorectal cancer) This
will lend one to stratify an individual's
risk, develop alternative methods ofdetec-
tion such as fecal DNA sampling in spo-
radic cases, and bring about novel medical
treatments involving biological therapies
such as vaccines [64].Angiogenesis appears
to have come to the forefront ofcolorectal
cancer investigation with the realization
that the growth of tumors is dependent on
angiogenic factors [65]. Chemoprevention
involving dietary supplements such as cal-
cium and folic acid or the daily administra-
tion ofcompounds thatblockcritical enzyme
pathways implicated in carcinogenesis
such as cyclooxygenase continue to receive
attention [66]. Continued emerging surgical
technology will involve reducing surgical
stress and its potential immunologic con-
sequences by utilizing surgical trauma.
Understanding the mechanisms of the
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cytokine antagonists, growth hormone and
colon stimulating factors have and will
continue to impact favorably in intestinal
inflammatory states. Inflixamib (Remicaid)
is a anti-tumor necrosis factor compound
which has had a major impact in refractory
fistulizing Crohn's disease involving the
intestine and the anorectum. From this
landmark study, it is reasonable to assume
that other compounds will be developed to
regulate the inflammatory cascade. This will
clearly be aidedby the furtherunderstanding
of the molecular events that occur during
inflammation.
Surgeons with expertise in colon and
rectal surgery are often called upon by their
medical counterparts to evaluate patients
with a variety of functional bowel disor-
ders often manifested by abdominal orpelvic
pain, cramping, constipation, diarrhea and
incontinence. The benefits of colectomy
for chronic constipation in highly selected
patents and a combination of bowel
retraining, biofeedback, and, where applic-
able, anal sphincter repair for fecal incon-
tinence have been well established.
However, a tremendous amount of time
and healthcare resources have been uti-
lized in patients with other functional dis-
orders often with variable or unfavorable
results. Recent advances in the understand-
ing ofneurotransmitters and gut hormones
that regulate intestinal physiology have
come to the forefront. After many years of
failure of compounds such as cholinergic
agonists and dopamine antagonists, highly
focused research has directed physicians to
learn how to manipulate the serotoninergic
(5-hydroxytryptamine-5HT) mechanisms
within the gut. A number of significant
advances including 5-HT3 antagonists for
diarrhea predominant irritable bowel and
5-HT4 agonists for constipation irritable
bowel have been met with favorable
results [67].
CONCLUDING REMARKS
Colon and rectal surgery is a true spe-
cialty. Expertise can have afavorable impact
on patients afflicted with afflictions of the
colon, rectum, and anus. Itwill impactfavor-
ably on patients who develop rectal cancer
by both increased number ofsphincter pre-
serving procedures and decreased local
recurrence, increased the numberandqual-
ity of restorative procedures for ulcerative
colitis, offer alternatives for patients with
disabling fecal incontinence, result in
diminished complications following surgery
for benign anorectal disease and overall
diminish the number of patients who
require an intestinal stoma. Within the aca-
demic setting, the path is clearly paved for
novel and influential research initiatives in
both the basic sciences and translational
research. Itsmultifactorial role ineducation,
character building and as a role model has
yet to be fully realized but will continue to
come ofage.
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